Oppenheimer upgraded Edwards Lifesciences to Outperform from Perform with a $90 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EW:
- Early notable gainers among liquid option names on September 26th
- Edwards Lifesciences price target lowered to $83 from $88 at Piper Sandler
- Edwards Lifesciences (NYSE:EW) Q2 Results Leave Analysts Divided; Stock Down 10%
- Edwards Lifesciences price target raised to $88 from $83 at Piper Sandler
- Edwards Lifesciences price target lowered to $89 from $96 at Canaccord